Document Detail

Relationship between preoperative hypometabolism and surgical outcome in neocortical epilepsy surgery.
MedLine Citation:
PMID:  22709127     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Fluorine-18-fluorodeoxyglucose-positron emission tomography (FDG-PET) hypometabolism has been used to localize the epileptogenic zone. However, glucose hypometabolism remote to the ictal focus is common and its relationship to surgical outcome has not been considered in many studies. We investigated the relationship between surgical outcome and FDG-PET hypometabolism topography in a large cohort of patients with neocortical epilepsy.
METHODS: We identified all patients (n = 68) who had interictal FDG-PET between 1994 and 2004 and who underwent resective epilepsy surgery with follow up for more than 2 years. The volumes of significant FDG-PET hypometabolism involving the resected epileptic focus and its surrounding regions (perifocal hypometabolism) and those distant to and not contiguous with the perifocal hypometabolism (remote hypometabolism) were determined statistically using Statistical Parametric Mapping (voxel threshold p = 0.01, extent threshold ≥ 250 voxels, uncorrected cluster-level significance p < 0.05) and were compared with magnetic resonance imaging (MRI) and clinical and demographic variables using a multiple logistic regression model to identify independent predictors of seizure outcome.
KEY FINDINGS: Remote hypometabolism was present in 39 patients. Seizure freedom was 49% (19 of 39 patients) in patients with glucose hypometabolism remote from the epileptogenic zone compared to 90% (26 of 29 patients) in patients without remote hypometabolism. In 43 patients with an MRI-identified lesion, seizure freedom was 79% (34 of 43 patients). In patients with normal MRI, cortical dysplasia was the predominant pathologic substrate. Multiple logistic regression analysis identified a larger volume of significant remote hypometabolism (p < 0.005) and absence of a MRI-localized lesion (p = 0.006) as independent predictors of continued seizures after surgery.
SIGNIFICANCE: In patients with widespread glucose hypometabolism that is statistically significant when compared to controls, epilepsy surgery may not result in complete seizure freedom despite complete removal of the MRI-identified lesion. The volume of significant glucose hypometabolism remote to the ictal-onset zone may be an independent predictor of the success of epilepsy surgery.
Chong H Wong; Andrew Bleasel; Lingfeng Wen; Stefan Eberl; Karen Byth; Michael Fulham; Ernest Somerville; Armin Mohamed
Related Documents :
14768517 - Normal pressure hydrocephalus found after anesthesia--a case report.
9021787 - Bladder compliance in patients with benign prostatic hyperplasia.
10436427 - Diagnostic value of voided urine and bladder barbotage cytology in detecting transition...
4051447 - Hepatic acetylator phenotype in bladder cancer patients.
21159837 - Temporomandibular joint involvement in children with juvenile idiopathic arthritis.
10348467 - Camptocormia (bent spine) in patients with parkinson's disease--characterization and po...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-06-18
Journal Detail:
Title:  Epilepsia     Volume:  53     ISSN:  1528-1167     ISO Abbreviation:  Epilepsia     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-13     Completed Date:  2012-10-26     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1333-40     Citation Subset:  IM    
Copyright Information:
Wiley Periodicals, Inc. © 2012 International League Against Epilepsy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain / metabolism*,  pathology
Epilepsies, Partial / metabolism,  pathology,  surgery
Epilepsy / metabolism,  pathology,  surgery*
Epilepsy, Frontal Lobe / metabolism,  pathology,  surgery
Epilepsy, Temporal Lobe / metabolism,  pathology,  surgery
Fluorodeoxyglucose F18
Glucose / metabolism
Magnetic Resonance Imaging
Positron-Emission Tomography
Treatment Outcome
Young Adult
Reg. No./Substance:
0Z5B2CJX4D/Fluorodeoxyglucose F18; IY9XDZ35W2/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antimicrobial and Biofilm Inhibiting Diketopiperazines.
Next Document:  Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term associa...